- Formosa Plastics reported a 2Q net income of NT$220.9 million, falling short of the estimated NT$1.77 billion.
- The company posted an operating loss of NT$1.45 billion, contrary to the expected profit of NT$2.23 billion.
- The revenue stood at NT$48.11 billion, with it being lower than the estimated NT$51.59 billion.
- The Earnings per Share (EPS) is calculated at NT$0.030, much less than the anticipated NT$0.32.
- Pertaining to investment ratings, the company has received 1 ‘buy’ rating, 8 ‘hold’ ratings, and 3 ‘sell’ ratings.
A look at Formosa Plastics Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 2 | |
| Resilience | 3 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Formosa Plastics Corporation, a company that manufactures a variety of plastics materials and chemical fiber products, has received high scores in Value and Dividend aspects, indicating strong metrics in these areas. The company’s robust performance in these categories suggests a positive long-term outlook for investors seeking value and dividends from their investments.
However, Formosa Plastics has lower scores in Growth, Resilience, and Momentum, which may imply challenges in these areas that could impact its future prospects. Investors should consider these factors alongside the company’s strong value and dividend profiles when assessing their investment decisions in Formosa Plastics.
Summary: Formosa Plastics Corporation is a manufacturer of PVC resins, high-density polyethylene, acrylic fiber, and other chemical products. The company has received high scores in Value and Dividend, but lower scores in Growth, Resilience, and Momentum, indicating a mixed outlook for investors.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
